Paragraph 3 Neurological conditions resulting in long-term severe physical disability

(1)

A person (“P”) is to be treated as having a neurological condition resulting in long-term severe physical disability if—

(a)

P has—

(i)

HIV and has been diagnosed with any of the conditions listed in sub-paragraph (2);

(ii)

a Hepatitis B infection of severity level 2, 3 or 4 and has been diagnosed with any of the conditions listed in sub-paragraph (3);

(iii)

a Hepatitis C infection of severity level 2, 3 or 4 and has been diagnosed with any of the conditions listed in sub-paragraph (4), and

(b)

P has been assessed as needing at least level 2 care as a result of the diagnosed condition.

(2)

The conditions referred to in sub-paragraph (1)(a)(i) are—

(a)

any of the following conditions, if the condition is secondary to advanced HIV disease and neoplasia secondary to that disease—

(i)

cerebral toxoplasmosis;

(ii)

central nervous system tuberculosis;

(iii)

cytomegalovirus encephalitis;

(iv)

varicella zoster virus encephalitis;

(v)

herpes simplex virus encephalitis;

(vi)

Epstein Barr virus encephalitis;

(vii)

progressive multifocal leucoencephalopathy;

(viii)

cryptococcal meningitis;

(ix)

primary central nervous system lymphoma;

(x)

thromboembolic disease secondary to bacterial or fungal endocarditis;

(b)

any of the following conditions, secondary to, or associated with, HIV infection—

(i)

HIV vacuolar myelopathy;

(ii)

transverse myelitis;

(iii)

thrombotic thrombocytopenic purpura;

(iv)

cerebrovascular ischaemic or haemorrhagic stroke;

(v)

coagulopathies: Antiphospholipid syndrome;

(vi)

chronic inflammatory demyelinating polyneuropathy;

(vii)

cytomegalovirus polyradiculopathy;

(viii)

HIV myopathy.

(3)

The conditions referred to in sub-paragraph (1)(a)(ii) are—

(a)

peripheral neuropathy caused by mixed cryoglobulinaemic vasculitis that results in mobility disability;

(b)

peripheral neuropathy occurring in the context of Hepatitis B-associated polyarteritis nodosa that results in mobility disability.

(4)

The conditions referred to in sub-paragraph (1)(a)(iii) are—

(a)

cryoglobulinaemic vasculitis induced neurological disease that results in mobility disability;

(b)

peripheral neuropathy caused by mixed cryoglobulinaemic vasculitis that results in mobility disability.